BRD2 and infection: The analysis was based on the results of HBsAg and HBV DNA screening performed in the years 2005–2019 in first-time and repeat donors, taking into account seropositive (HBsAg positive) and seronegative (NAT yield—HBsAg-/DNA HBV+) infections and demographic factors (gender, age).